Iridex reported revenue of $10 million in the second quarter of 2017 compared with $11.9 million in the same time period last year, according to a company press release. The decrease was attributed to lower revenue for medical retina products.
Author: Healio ophthalmology
Trump administration committed to battling opioid crisis
Today in Bedminster, New Jersey, President Donald J. Trump held a “major briefing” with the HHS on the current opioid epidemic in the United States and the department’s strategy to fight it.During a separate press briefing, HHS Secretary Tom Price, MD, emphasized the president’s absolute commitment to “turning this tide in the right direction” and ensuring that the number of overdose deaths and individuals addicted to medication decrease.
Carl Zeiss Meditec reports 8.3% increase in 9-month revenue
In the first 9 months of its 2016-2017 fiscal year, Carl Zeiss Meditec reported an 8.3% increase in revenue to 864.7 million, or 1.10 per share, compared with 798.6 million, or 0.83 per share, a year ago. Revenue in the ophthalmic devices business unit…
Medical schools evolve to prepare for opioid crisis, still ‘a long way to go’
The Commission on Combating Drug Addiction and the Opioid Crisis recently issued a recommendation to President Donald J. Trump to declare a national emergency to combat the growing opioid epidemic. “Your declaration would empower your cabinet to take bold steps and would force Congress to focus on funding,” New Jersey Gov. Chris Christie and bipartisan committee members wrote. “It would also awaken every American to this simple fact: if this scourge has not found you or your family yet, without bold action by everyone, it soon will.”
Correlations between risk factors and haze after PRK identified
A large cohort study investigating factors associated with the development of haze after PRK found significant correlations with hyperopia, high myopia and high astigmatism. Longer mitomycin C application and laser removal of the epithelium rather than…
Clearside completes enrollment in trial of noninfectious uveitis treatment
Patient enrollment in the phase 3 PEACHTREE trial of a treatment for macular edema associated with noninfectious uveitis has been completed, according to a press release from Clearside Biomedical. The randomized, masked, sham-controlled clinical trial …
Bascom Palmer named best in ophthalmology again
Bascom Palmer Eye Institute has topped U.S. News & World Report’s annual list of best hospitals for ophthalmology for the 14th consecutive year.This marks the 16th time the University of Miami-based institution was named at the top of the list since the publication first began its rankings 28 years ago.
Glaukos reports $3.3 million net loss in second quarter
Glaukos reported a net loss of $3.3 million, or $0.10 per diluted share, in the second quarter of 2017 compared with a net income of $2.3 million, or $0.06 per diluted share, in the second quarter of 2016. Net sales increased from $28.6 million a year …
FDA responds to NDA for glaucoma drug
The FDA has sent a complete response letter to Valeant Pharmaceuticals regarding the new drug application for the Bausch + Lomb latanoprostene bunod ophthalmic solution 0.024% product called Vyzulta.The investigational single-agent IOP-lowering eye dro…
Swept-source OCT protocol may limit prone position time after macular hole surgery
A swept-source OCT imaging protocol helped reduce the prone position time of patients undergoing vitrectomy without reopening the macular hole, according to a study.Compared with conventional fundus examinations by indirect ophthalmoscopy, patients imaged with SS-OCT experienced statistically significantly less time in the prone position before macular hole closure. Researchers studied 129 eyes of 125 consecutive patients with macular hole who had undergone vitrectomy. The prone position was halted by a surgeon’s decision in 69 eyes of 66 patients in the conventional group, while it was halted after SS-OCT detected closure (Read more...)
Guardion Health Sciences completes Series B funding
Guardion Health Sciences announced it has completed a Series B funding round with $3.1 million raised, according to a company press release.The money is to be used in accelerating expansion of the company’s operations, implementing its sales and marketing strategy, and completing development of products in its pipeline, the release said.
Alimera sees second quarter revenue increase
Alimera Sciences had an increase in consolidated net revenue of 8% to $10.4 million in the second quarter of 2017 compared with $9.6 million in the second quarter of 2016. U.S. revenue increased from $7.2 million to $8.1 million, driven by higher sales…
PUBLICATION EXCLUSIVE: Visualization during surgery continues to evolve
Intraoperative OCT is showing promise as a useful adjunct, especially in vitrectomy and lamellar keratoplasty. However, indications are limited, as vitrectomy only represents about 2% of ophthalmic surgical procedures in the U.S., or about 250,000 procedures per year. Endothelial and lamellar anterior keratoplasty represent only 0.25% of procedures, or about 30,000 per year.In vitrectomy, early adopter surgeons are finding intraoperative OCT helpful when peeling epiretinal membranes and treating other vitreoretinal interface pathologies. Intraoperative OCT can help differentiate retinoschisis from retinal detachment. It is also potentially helpful in select surgical procedures (Read more...)
PUBLICATION EXCLUSIVE: Real-time imaging adds interactive dimension to vitreoretinal, surgery training
First introduced in the early 1990s, OCT is a noninvasive imaging technique that obtains high-resolution, cross-sectional images of the retina and other ophthalmic tissues.In recent years, this technology has transitioned from being only available in t…
Intraretinal cystoid fluid height may predict functional improvement
Height of intraretinal cystoid fluid served as a better predictor of functional and anatomical outcomes than central retinal thickness in patients treated with ranibizumab for diabetic macular edema, according to a study.Researchers conducted a post ho…
Allergan reports Q2 net revenue increase
Allergan reported its second quarter 2017 operations performance, including total net revenues of $4 billion, which was a 9% increase from the same quarter a year earlier.The revenue growth was driven by Botox (onabotulinumtoxinA) and the Juvederm (inj…
5 pieces of social media advice for medical students
In this guest commentary, Angela Showell, social media and public affairs manager at Thomas Jefferson University and former associate director of electronic communications at Temple University, discusses some best practice measures for medical students’ social media use .
Johnson & Johnson Vision to acquire TearScience
Johnson & Johnson Vision announced it will acquire TearScience through Abbott Medical Optics, its surgical vision operating company, according to a company press release.Financial terms of the acquisition, which is expected to close by the end of the year, were not disclosed.
SalutarisMD launches trial of brachytherapy treatment for wet AMD
A clinical trial of an ophthalmic brachytherapy device for neovascular age-related macular degeneration has been launched, according to a press release from Salutaris Medical Devices. The trial will study the safety, surgeon ease of use and tolerabilit…
FDA gives orphan drug designation for retinitis pigmentosa gene therapy
The FDA has given orphan drug designation to a gene therapy product intended for treatment of X-linked retinitis pigmentosa, Applied Genetic Technologies Corp. announced in a press release.The drug candidate, which is intended specifically to treat X-l…